SACOA BIOPEST PARAFFINIC OIL Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sacoa biopest paraffinic oil

dksh agrisolutions pty ltd - paraffinic oil - emulsifiable concentrate - paraffinic oil petroleum derivative-oil active 815.0 g/l - insecticide - adjuvant | almond | apple | apricot | asparagus | avocado | azalea | banana | bean | bed - plant - general | beet | begonia | bl - additive - refer to label | aphid | aphid eggs | black scale | black spot on citrus | brown mite | bug | carmine mite | carrier - ulv insecticide | cercospora leaf spot | circular black scale | citrus leafminer | cordana leaf spot | cotton aphid | defoliation of cotton plants | european red mite | european red mite (erm) - eggs | grapevine scale | leaf polish | leaf speckle on banana | leafhopper | mango planthopper | mealy bug | mite | mite - egg | pear rust mite | pearleaf blister mite | pinkwax scale | powdery mildew | red scale | san jose' scale | scale | scale - hard | scale insects | soft brown scale | soft scale | spider mite | thrip | weed control - refer to additive label | white wax scale | whitefly | whitefly - immature | apple dimpling bug | brokenbacked bug | brown smudge bug | citrus red scale | defoliation aid | diaspidiotus perniciosus | eriophyes pyri | green mirid | green vegetable bug | mealybug | melon aphid | quadraspidiotus perniciosus | red spider mite | rutherglen bug | spider mite | t

Oxycodone Juno oxycodone hydrochloride 50 mg / 1 mL solution for infusion ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone juno oxycodone hydrochloride 50 mg / 1 ml solution for infusion ampoule

juno pharmaceuticals pty ltd - oxycodone hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated, or are otherwise inappropriate to provide sufficient management of pain.

Oxycodone Juno oxycodone hydrochloride 200 mg / 20 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone juno oxycodone hydrochloride 200 mg / 20 ml solution for injection ampoule

juno pharmaceuticals pty ltd - oxycodone hydrochloride, quantity: 200 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated, or are otherwise inappropriate to provide sufficient management of pain.

Oxycodone Juno oxycodone hydrochloride 20 mg / 2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone juno oxycodone hydrochloride 20 mg / 2 ml solution for injection ampoule

juno pharmaceuticals pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated, or are otherwise inappropriate to provide sufficient management of pain.

Oxycodone Juno oxycodone hydrochloride 10 mg / 1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone juno oxycodone hydrochloride 10 mg / 1 ml solution for injection ampoule

juno pharmaceuticals pty ltd - oxycodone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated, or are otherwise inappropriate to provide sufficient management of pain.